PolyPid Ltd.

General ticker "PYPD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $15.9M (TTM average)

PolyPid Ltd. follows the US Stock Market performance with the rate: 54.8%.

Estimated limits based on current volatility of 3.1%: low 4.25$, high 4.53$

Factors to consider:

  • Total employees count: 65 as of 2020
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.82$, 5.89$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.55$, 5.11$]

Financial Metrics affecting the PYPD estimates:

  • Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -118.67 <= 0.04
  • Negative: negative Industry operating cash flow (median)
  • Positive: 19.35 < Shareholder equity ratio, % of 30.47 <= 42.53
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term PYPD quotes

Long-term PYPD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM
Operating Expenses $22.87MM $28.03MM
Operating Income $-22.87MM $-28.03MM
Non-Operating Income $-0.93MM $-0.95MM
Interest Expense $1.71MM $1.52MM
R&D Expense $16.15MM $22.81MM
Income(Loss) $-23.80MM $-28.98MM
Taxes $0.07MM $0.04MM
Profit(Loss)* $-23.86MM $-29.02MM
Stockholders Equity $-2.10MM $7.68MM
Assets $15.37MM $25.22MM
Operating Cash Flow $-17.24MM $-21.96MM
Capital expenditure $0.20MM $0.08MM
Investing Cash Flow $3.80MM $-0.33MM
Financing Cash Flow $9.98MM $32.42MM
Earnings Per Share** $-16.99 $-4.91

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.